{
    "nct_id": "NCT06534008",
    "official_title": "The Effect of Combined Aerobic and Muscle Strengthening Exercises on Structural and Functional Cardiovascular Adaptations in Endometrial Cancer Survivors",
    "inclusion_criteria": "Inclusion Criteria\n\n* Willing and able to provide written informed consent\n* Willing to comply with study procedures and available for the duration of the study\n* Fluent in spoken and written English\n* Women 18 years of age or older\n* Documented diagnosis of Type I, stage I-IIIc endometrial cancer within the past 5 years\n* Completion of current cytotoxic treatment for endometrial cancer\n* Technology access (phone call access, broadband internet, Wi-Fi) for tele coaching\n* Comfort and willingness to use technology (videoconferencing) throughout the study for coaching\n* Pass the Physical Activity Readiness Questionnaire (PAR-Q)\n* Medical clearances given by their primary provider / oncologist (if indicated by the PAR-Q)\n\nExclusion Criteria\n\n* Absolute contraindications to exercise (i.e., acute myocardial infarction, severe orthopedic or musculoskeletal limitations)\n* History of previous myocardial infarction, ischemia, or hemorrhagic stroke\n* Medically documented history of heart disease including heart valve disease, coronary artery disease, heart failure, peripheral artery disease, aortic disease, pericardial disease, cerebrovascular disease, or deep vein thrombosis\n* Medical documentation of treatment-resistant hypertension OR taking ≥2 medications to treat hypertension\n* Medically documented history of cardiovascular disease including (but not limited to): bypass surgery, stent procedures, bypass grafts, or coronary angioplasty\n* Medically documented or self-reported type 1 diabetes (insulin-dependents)\n* Prescriptions for or use of semaglutide (GLP-1 agonists) including name brands: Ozempic, Wegovy or Mounjaro\n* Current or recent (within last 3 months) use of hormone replacement therapy (HRT)\n* Evidence of recurrent or metastatic disease\n* Currently performing resistance training ≥2 days per week\n* Currently exceeding 150 minutes of at least moderate intensity exercise per week\n* Report of chest pain, shortness of breath, fainting, or angina pectoris\n* Self-reported history of falling, fall risk\n* Have physical disability that would limit range of motion through exercises such as sitting, standing and inability to walk one block\n* Plans to move from the area\n* Enrolled in another clinical trial or has used of any investigational drugs, biologics, or devices within 30 days prior to study enrollment\n* Self-reported tobacco use in last 7 days, current smoking, current tobacco use including e-cigarettes and vaping devices\n* Not suitable for study participation due to other reasons at the discretion of the investigator\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}